STAT· @statnews · X·· 12 天前AI 评分50
AI 导读
STAT 报道,一项历时十年开发的镰状细胞病基因编辑疗法试验在三年前因首例患者出现严重不良事件而突然中止。该疗法如今出现新进展,但原文正文在此处截断,未披露具体结果。
正文
Three years ago, a trial for a sickle cell gene-editing therapy a decade in the making ended abruptly after the first patient suffered a serious adverse event. Now, the therapy… https://trib.al/a134YHb
来源:STAT · x.com